Photodynamic Therapy in Treatment of Verrucae

Last updated: July 23, 2021
Sponsor: Alexandria University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Warts

Human Papilloma Virus (Hpv)

Treatment

N/A

Clinical Study ID

NCT04620785
0106171
  • Ages > 16
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

To assess the efficacy (clinically and dermoscopically) and safety of photodynamic therapy using intralesional injection of 4% methylene blue solution as a photosensitizer with IPL versus IPL only in treatment of warts.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Age:Above 16 years old.
  2. Sex:Both males and female patients.
  3. Clinically and dermoscopically documented verruca.
  4. No verruca treatment in the last 2 weeks.

Exclusion

Exclusion Criteria:

  1. History of photosensitivity disorder.
  2. Pregnant and lactating females.
  3. Diseases with risk of koebnerization e.g. Psoriasis and Lichen planus.
  4. Anogenital warts.
  5. Warts on head and neck.

Study Design

Total Participants: 80
Study Start date:
January 01, 2020
Estimated Completion Date:
May 01, 2022

Study Description

This study will be conducted on:

Eighty patients suffering of verruca (male and female) divided randomly into three groups: group A, B&C :

Group A: 30 patients will undergo photodynamic therapy using intralesional 4%methylene blue solution and IPL.

Group B: 30 patients will undergo IPL only. Group C (control group):20 patients will undergo intralesional saline.

Connect with a study center

  • Alexandria University Faculty of Medicine

    Alexandria,
    Egypt

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.